Skip to main content
    O

    Opko Health Inc (OPK)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $1.62
    -0.06 (-3.57%)

    Market Cap: $1.25B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Opko Health Inc (OPK) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Opko Health are NeoGenomics (NEO), Personalis (PSNL) and Castle Biosciences (CSTL). By market cap, Opko Health ranks 9th of the 13 companies on this page; ICON (ICLR) is the largest at $14.58B. The median P/E of the 5 companies with a P/E is 20.0x.

    Peer Comparison

    OPK's ROIC of -6.2% is below the peer median of 2.8%, and its revenue growth of 15.9% is above the median of 9.4%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Opko Health (OPK)$1.25BN/A2.4x-22.6%-6.2%15.9%0.00%
    NeoGenomics Inc (NEO)$2.07B228.9x2.6x-4.1%-2.5%11.4%0.00%
    Personalis Inc (PSNL)$1.70BN/A20.9x-147.7%N/A76.6%0.00%
    Castle Biosciences Inc (CSTL)$1.04BN/A2.7x-6.1%-5.4%23.9%0.00%
    Veracyte Inc (VCYT)$1.96B13.3x3.3x21.8%8.2%15.1%0.00%
    Fulgent Genetics Inc (FLGT)$688.98MN/A2.0x-27.5%-12.1%7.5%0.00%
    Myriad Genetics Inc (MYGN)$542.92MN/A0.7x-16.1%-29.5%-1.5%0.00%
    CareDx Inc (CDNA)$4.09B48.2x6.4x25.9%N/A39.3%0.00%
    Sotera Health Co (SHC)$4.74B17.1x3.8x14.1%9.0%4.4%0.00%
    Adaptive Biotechnologies Corp (ADPT)$4.70BN/A15.0x-23.7%N/A-10.7%0.00%
    Omeros Corporation (OMER)$1.27BN/A16.4x324.9%33.6%14.9%0.00%
    ICON PLC (ICLR)$14.58B20.0x1.8x5.3%2.8%-2.9%0.00%
    Insight Molecular Diagnostics Inc. (IMDX)$70.03MN/A40.9x0.0%197.8%-53.9%0.00%
    Peer median$1.83B20.0x3.6x-2.0%2.8%9.4%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Opko Health, ranked by how closely their business, size, sector and industry match. The largest group, 11 of the 12, is in Diagnostics & Research; the other one is in Biotechnology.

    CompanyAboutPeers
    NeoGenomics Inc (NEO)Diagnostics & Research
    NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia.
    NEO competitors
    Personalis Inc (PSNL)Diagnostics & Research
    Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
    PSNL competitors
    Castle Biosciences Inc (CSTL)Diagnostics & Research
    Castle Biosciences Inc. is a pioneering diagnostics firm that enhances patient care through advanced gene-expression profiling tests...
    CSTL competitors
    Veracyte Inc (VCYT)Diagnostics & Research
    Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California.
    VCYT competitors
    Fulgent Genetics Inc (FLGT)Diagnostics & Research
    Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information.
    FLGT competitors
    Myriad Genetics Inc (MYGN)Diagnostics & Research
    Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized...
    MYGN competitors
    CareDx Inc (CDNA)Diagnostics & Research
    CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally.
    CDNA competitors
    Sotera Health Co (SHC)Diagnostics & Research
    Sotera Health Company provides sterilization, laboratory testing, and advisory services to the medical device, pharmaceutical...
    SHC competitors
    Adaptive Biotechnologies Corp (ADPT)Diagnostics & Research
    Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.
    ADPT competitors
    Omeros Corporation (OMER)Biotechnology
    Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and markets protein and small molecule therapies...
    OMER competitors
    ICON PLC (ICLR)Diagnostics & Research
    ICON Public Limited Company, a clinical research organization, provides outsourced marketing and development services in Ireland, the rest of Europe...
    ICLR competitors
    Insight Molecular Diagnostics Inc. (IMDX)Diagnostics & Research
    OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California.
    IMDX competitors

    Frequently Asked Questions About OPK

    Who are Opko Health's main competitors?

    The companies most similar to Opko Health include NeoGenomics (NEO), Personalis (PSNL), Castle Biosciences (CSTL), Veracyte (VCYT) and Fulgent Genetics (FLGT), listed from the closest match.

    Who is Opko Health's biggest competitor?

    ICON (ICLR) is the largest of the similar companies at $14.58B; NeoGenomics (NEO) is the closest match by business profile, size, sector and industry.

    How does OPK stock compare with its competitors?

    OPK's P/S is 2.4x against a peer median of 3.6x; its net margin is -22.6% against a peer median of -2.0%.

    Which of Opko Health's competitors pays a higher dividend?

    Opko Health pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Opko Health bigger than its competitors?

    No. Opko Health is 9th by market cap among the 13 companies on this page; the largest is ICON (ICLR) at $14.58B.